{
  "docId": "019de516-01ce-701d-bd9b-acac15fa9fab",
  "docSlug": "a13be9775a99db49a0c5c2ac3ee2ea88",
  "documentTitle": "Oculis | Investor Conference Presentation Deck | 39 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 33,
  "pageCount": 39,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-01ce-701d-bd9b-acac15fa9fab/33",
  "deckHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab",
  "deckJsonHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab.json",
  "deckAnchorHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.29,
        "w": 0.46,
        "x": 0.508,
        "y": 0.38
      },
      "kind": "diagram",
      "text": "Several neuro-ophtha indications under consideration: Acute Optic Neuritis (AON), Glaucoma, Geographic Atrophy, Diabetic Retinopathy, Cornea: Neurotrophic Keratitis, CNS: Multiple Sclerosis (MS)",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e9003af2-d477-41b3-9ebe-c4c169282bb7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.11,
        "x": 0.85,
        "y": 0.04
      },
      "kind": "image",
      "text": "Oculis logo",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1dac3e0c-5985-4bbb-89e1-bc7cc83901d5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.31,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "list",
      "text": "Oculis New Sponsor Q3 2022",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34c5e2ea-59e1-4ad7-a935-d93cff117f72",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.53,
        "x": 0.05,
        "y": 0.81
      },
      "kind": "list",
      "text": "Oculis is working with FDA on pursuing development in the U.S. (1)",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7690e8a9-51b7-4fd6-9514-279c04e07b65",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.41,
        "x": 0.05,
        "y": 0.301
      },
      "kind": "list",
      "text": "Previous and ongoing studies in Europe",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e07657c6-54e1-4416-b3d8-f67392f03977",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.47,
        "x": 0.05,
        "y": 0.578
      },
      "kind": "paragraph",
      "text": "Phase 2a: First-in-patient trial in AON\nObjective to evaluate safety and explore efficacy of OCS-05 compared to placebo in patients diagnosed with a first unilateral AON of a demyelinating origin\nRandomized, double-blind, placebo-controlled, multi-center trial in France",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "93d1d6b1-8ea6-44e7-b335-375cd27dce2e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.47,
        "x": 0.05,
        "y": 0.36
      },
      "kind": "paragraph",
      "text": "Phase 1: No drug-related side effects\nRandomized, double-blind, placebo-controlled, single and multiple ascending dose study of the safety, tolerability and PK in adult healthy volunteers (UK, MHRA)\nRecruitment of 48 healthy volunteers (36 OCS-05, 12 placebo)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "faef95a7-4422-4ec8-bd94-b9a55d7a6a9f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.24,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "(1) U.S. Clinical hold in 2016 under prior sponsor.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a237c7e-c833-441e-872b-c4789a1d6d2a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.36,
        "x": 0.026,
        "y": 0.098
      },
      "kind": "title",
      "text": "Paving the way to multiple indications",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd9e9f19-3de0-49f3-9608-0bb90528d33e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.036,
        "w": 0.41,
        "x": 0.026,
        "y": 0.056
      },
      "kind": "title",
      "text": "OCS-05 | Development Status",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "44879971-f281-4e40-85dc-b1bff0b55e99",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 25,
      "beatId": "6cce666b-f795-4a3e-a589-afe2a7266ece",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 25-39 discuss OCS-02, OCS-05, and the track record of efficient capital deployment.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}